Clinical Trial Adult ALD Men

Minoryx initating next phase in trial

“Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral Adrenoleukodystrophy. CALYX will enroll 40 adult male X-ALD patients with progressive cALD defined by the presence of gadolinium enhancing brain lesions.”

To read the full press release:


Alex - The Leukodystrophy Charity